Johnson Bixby & Associates’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Buy
11,913
+98
+0.8% +$2.04K 0.03% 118
2026
Q1
$247K Buy
11,815
+90
+0.8% +$1.9K 0.03% 115
2025
Q4
$248K Buy
11,725
+1,177
+11% +$24.9K 0.03% 106
2025
Q3
$224K Buy
10,548
+125
+1% +$2.63K 0.03% 114
2025
Q2
$219K Buy
10,423
+128
+1% +$2.64K 0.03% 113
2025
Q1
$214K Buy
10,295
+84
+0.8% +$1.72K 0.03% 109
2024
Q4
$208K Buy
10,211
+166
+2% +$3.43K 0.03% 113
2024
Q3
$213K Buy
10,045
+123
+1% +$2.56K 0.03% 105
2024
Q2
$201K Buy
9,922
+125
+1% +$2.52K 0.03% 108
2024
Q1
$201K Buy
9,797
+79
+0.8% +$1.61K 0.03% 112
2023
Q4
$202K Buy
+9,718
New +$191K 0.04% 106

Other funds holding IBDW

Johnson Bixby & Associates's IBDW Position: Q2 2026 in Review

Johnson Bixby & Associates increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 0.83% in Q2 2026, buying an estimated $2.04K and bringing the position to 11,913 shares worth $248K. The position accounts for 0.03% of the portfolio, ranked #118.

Johnson Bixby & Associates first reported a position in IBDW in Q4 2023 and has held it in 11 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Johnson Bixby & Associates held 11,913 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $248K as of Q2 2026.
  • Johnson Bixby & Associates bought 98 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $2.04K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.03% of Johnson Bixby & Associates's portfolio in Q2 2026, its #118 holding.
  • Johnson Bixby & Associates first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Johnson Bixby & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.